Actos is a prescription medication used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Actos works on two of the common problems that lead to high blood sugar in type 2 diabetes. Actos helps your body better use the insulin it makes and also stops your liver from making more sugar when it doesn’t need to.
Users of the drug Actos, who already confront its association with heart failure, may now also confront bladder cancer. The FDA has recently approved updated drug labels for pioglitazone-containing medicines (The active ingredient in Actos, ActoPlus met, ActoPlus met XR and Duetac) to include safety information that the use of pioglitazone may be associated with an increased risk of bladder cancer. Determining whether ACTOS or other pioglitazone-containing medicines contributed to an individual’s bladder cancer requires a case-sensitive in depth review of medical history.
If you or anyone you know has been diagnosed with bladder cancer and was prescribed Actos, ActoPlus met, ActoPlus met XR or Duetac (Pioglitazone) to treat Type 2 Diabetes, contact us now for a free evaluation.